Design and synthesis of small molecules and nanoparticle conjugates for cell type-selective delivery

Histone deacetylase (HDAC) inhibition is an emerging novel therapeutic strategy in cancer therapy. HDAC inhibitors (HDACi) have shown ability to block angiogenesis and cell cycling, as well as initiate differentiation and apoptosis. In fact, suberoylanilide hydroxamic acid (SAHA) is the first in t...

Full description

Bibliographic Details
Main Author: Chen, Po Chih
Published: Georgia Institute of Technology 2009
Subjects:
Online Access:http://hdl.handle.net/1853/28111